Figures & data
Table 1. Reported experimental thermodynamic data for fragment–protein binding.
Ferenczy GG, Keserű GM. Enthalpic efficiency of ligand binding. J Chem Inf Model. 2010;50:1536–1541. Steuber H, Heine A, Podjarny A, et al. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features. J Mol Biol. 2008;379:991–1016. Gloster TM, Macdonald JM, Tarling CA, et al. Structural, thermodynamic, and kinetic analyses of tetrahydrooxazine- derived inhibitors bound to β-glucosidases. J Biol Chem. 2004;279:49236–49242. Snyder PW, Mecinovic J, Moustakas DT, et al. Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase. Proc Natl Acad Sci. 2011;108:17889–17894. Scott AD, Phillips C, Alex A, et al. Thermodynamic optimisation in drug discovery: A case study using carbonic anhydrase inhibitors. Chem Med Chem. 2009;4:1985–1989. Mecinović J, Snyder PW, Mirica KA, et al. Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the “Hydrophobic Wall” of carbonic anhydrase. J Am Chem Soc. 2011;133:14017–14026. Binford JS, Lindskog S, Wadsö I. A calorimetric study of the binding of sulfonamides and cyanate to carbonic anhydrase. BBA - Enzymol. 1974;341:345–356. Protasevich II, Brouillette CG, Snow ME, et al. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: A proposed mechanism for drug resistance. Biochemistry. 2004;43:13380–13389. Dunford JE, Kwaasi AA, Rogers MJ, et al. Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem. 2008;51:2187–2195. Balendiran GK, Schnütgen F, Scapin G, et al. Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem. 2000;275:27045–27054. Murray CW, Carr MG, Callaghan O, et al. Fragment-based drug discovery applied to hsp90. discovery of two lead series with high ligand efficiency. J Med Chem. 2010;53:5942–5955. Bingham RJ, Findlay JBC, Hsieh SY, et al. Thermodynamics of Binding of 2-Methoxy-3-isopropylpyrazine and 2-Methoxy-3-isobutylpyrazine to the major urinary protein. J Am Chem Soc. 2004;126:1675–1681. Sharrow SD, Novotny MV, Stone MJ. Thermodynamic analysis of binding between mouse major urinary protein-I and the pheromone 2-sec-butyl-4,5-dihydrothiazole. Biochemistry. 2003;42:6302–6309. Bertini I, Calderone V, Fragai M, et al. Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases. J Am Chem Soc. 2007;129:2466–2475. Neumann L, Von Knig K, Ullmann D. HTS Reporter displacement assay for fragment screening and fragment evolution toward leads with optimized binding kinetics, binding selectivity, and thermodynamic signature. In: Kuo LC, editor. Methods Enzymol. Academic Press. 2011. vol. 493, p. 299–320. Papalia GA, Giannetti AM, Arora N, et al. Thermodynamic characterization of pyrazole and azaindole derivatives binding to p38 mitogen-activated protein kinase using Biacore T100 technology and van’t Hoff analysis. Anal Biochem. 2008;383:255–264. Silvestre HL, Blundell TL, Abell C, et al. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery. Proc Natl Acad Sci U S A. 2013;110:12984–12989. Scott DE, Dawes GJ, Ando M, et al. A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistry. ChemBioChem. 2009;10:2772–2779. Bullock AN, Debreczeni JÉ, Fedorov OY, et al. Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. J Med Chem. 2005;48:7604–7614. Dai R, Geders TW, Liu F, et al. Fragment-based exploration of binding site flexibility in mycobacterium tuberculosis BioA. J Med Chem. 2015;58:5208–5217. Poget SF, Legge GB, Proctor MR, et al. The structure of a tunicate C-type lectin from Polyandrocarpa misakiensis complexed with D-galactose. J Mol Biol. 1999;290:867–879. Wienen-Schmidt B, Wulsdorf T, Jonker HRA, et al. On the implication of water on fragment-to-ligand growth in kinase binding thermodynamics. Chem Med Chem. 2018;13:1988–1996. Calamini B, Santarsiero BD, Boutin JA, et al. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Biochem J. 2008;413:81–91. Fisher BM. Coulombic effects of remote subsites on the active site of ribonuclease A. Biochemistry. 1998;37:17386–17401. Weber PC, Pantoliano MW, Simons DM, et al. Structure-based design of synthetic azobenzene ligands for streptavidin. J Am Chem Soc. 1994;116:2717–2724. Baum B, Muley L, Smolinski M, et al. Non-additivity of functional group contributions in protein-ligand binding: A comprehensive study by crystallography and isothermal titration calorimetry. J Mol Biol. 2010;397:1042–1054. Rühmann E, Betz M, Fricke M, et al. Thermodynamic signatures of fragment binding: validation of direct versus displacement ITC titrations. Biochim Biophys Acta Gen Subj. 2015;1850:647–656. Perozzo R, Jelesarov I, Bosshard HR, et al. Compulsory order of substrate binding to herpes simplex virus type 1 thymidine kinase: A calorimetric study. J Biol Chem. 2000;275:16139–16145. Terán W, Krell T, Ramos JL, et al. Effector-repressor interactions, binding of a single effector molecule to the operator-bound TtgR homodimer mediates derepression. J Biol Chem. 2006;281:7102–7109. Dolezal O, Doughty L, Hattarki MK, et al. Fragment Screening for the Modelling Community: SPR, ITC, and Crystallography. Aust J Chem. 2013;66:1507. Talhout R, Engberts JBFN. Thermodynamic analysis of binding of p-substituted benzamidines to trypsin. Eur J Biochem. 2001;268:1554–1560. Ferenczy GG, Keserű GM. Thermodynamics of Ligand Binding. Luque J, Barril X, editors. Physico-Chemical Comput. Approaches to drug discov. RSC Drug Discov. Ser. Cambridge: Royal Society of Chemistry; 2012. p. 23–79.